Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedFeb 19, 2024
DataAggregated Company Financials
Companies11
  • 7D-0.6%
  • 3M-5.0%
  • 1Y-61.1%
  • YTDn/a

Over the last 7 days, the Biotech industry has risen 3.8%, driven by gains from Nykode Therapeutics of 11%. Meanwhile, ArcticZymes Technologies actually underperformed within the industry, shrinking 9.6% in the last week. However, the industry is down 60% over the past year. Looking forward, earnings are forecast to grow by 9.9% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 19 Feb 2024kr15.1bkr671.9m-kr1,003,515,434.3037.4x-15.1x22.5x
Wed, 17 Jan 2024kr16.8bkr656.8m-kr1,359,931,347.0058.7x-12.4x25.6x
Fri, 15 Dec 2023kr15.9bkr656.6m-kr1,359,602,735.0060.3x-11.7x24.3x
Sun, 12 Nov 2023kr14.1bkr642.4m-kr1,464,352,948.0056.5x-9.7x22x
Tue, 10 Oct 2023kr14.7bkr625.5m-kr1,458,651,115.0050.3x-10.1x23.6x
Thu, 07 Sep 2023kr15.6bkr627.1m-kr1,429,546,125.0058.6x-10.9x24.9x
Sat, 05 Aug 2023kr16.4bkr554.5m-kr1,449,376,434.0055.5x-11.3x29.6x
Mon, 03 Jul 2023kr15.1bkr561.6m-kr1,478,500,076.0060.8x-10.2x27x
Wed, 31 May 2023kr16.9bkr565.7m-kr1,509,054,866.0061.5x-11.2x29.9x
Fri, 28 Apr 2023kr16.4bkr541.3m-kr1,443,716,642.0030x-11.3x30.2x
Sun, 26 Mar 2023kr15.0bkr536.5m-kr1,556,728,452.0029.3x-9.7x28x
Tue, 21 Feb 2023kr18.5bkr825.4m-kr1,433,656,572.0032.7x-12.9x22.4x
Thu, 19 Jan 2023kr18.4bkr807.8m-kr1,393,647,595.0025.3x-13.2x22.8x
Sat, 17 Dec 2022kr20.6bkr808.9m-kr1,394,235,100.0041.7x-14.8x25.5x
Mon, 14 Nov 2022kr18.7bkr808.9m-kr1,355,620,015.0036.2x-13.8x23.1x
Wed, 12 Oct 2022kr17.0bkr817.8m-kr1,366,092,570.0036.6x-12.4x20.8x
Fri, 09 Sep 2022kr20.1bkr794.0m-kr1,367,555,311.0037.4x-14.7x25.3x
Sun, 07 Aug 2022kr21.9bkr768.5m-kr1,380,701,299.0045.9x-15.8x28.5x
Tue, 05 Jul 2022kr19.2bkr768.9m-kr1,380,816,704.0042.9x-13.9x25x
Thu, 02 Jun 2022kr22.4bkr1.1b-kr1,030,883,576.0039.8x-21.7x20.6x
Sat, 30 Apr 2022kr24.5bkr1.1b-kr989,576,266.0045.9x-24.8x23x
Mon, 28 Mar 2022kr26.5bkr2.6bkr374.4m10x70.8x10.1x
Wed, 23 Feb 2022kr26.1bkr2.7bkr434.6m9.8x60.1x9.7x
Fri, 21 Jan 2022kr34.2bkr2.2bkr38.0m37x900.1x15.7x
Sun, 19 Dec 2021kr39.0bkr2.2bkr74.3m40.2x525.4x17.5x
Tue, 16 Nov 2021kr38.9bkr2.6bkr476.5m15.6x81.6x14.9x
Thu, 14 Oct 2021kr38.0bkr2.6bkr469.5m15.8x80.8x14.9x
Sat, 11 Sep 2021kr39.7bkr2.6bkr508.1m17.3x78.1x15.4x
Mon, 09 Aug 2021kr38.5bkr2.6bkr508.1m16.2x75.8x15x
Sun, 02 May 2021kr41.3bkr2.5bkr545.4m18.5x75.8x16.3x
Price to Earnings Ratio

61.4x


Total Market Cap: kr40.1bTotal Earnings: kr652.4mTotal Revenue: kr2.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average 54.3x202220232024
Current Industry PE
  • Investors are relatively neutral on the Norwegian Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 21.4x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 36% per year, which is driving profits down.

Industry Comparison

How does Norwegian Biotech compare with similar industries?

NO Market0.31%
Healthcare-1.15%
Biotech-0.55%
Biotech-0.55%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NYKD Nykode Therapeuticskr18.816.7%
+kr385.3m
-35.5%PS40.3x
TRMED Thor Medicalkr1.131.3%
+kr3.3m
n/an/a
CRNA Circio Holdingkr6.303.3%
+kr1.5m
-75.4%PS4.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

TRMED

kr1.13

Thor Medical

7D

1.3%

1Y

n/a

HBC

kr2.40

Hofseth BioCare

7D

-2.4%

1Y

-13.7%

ULTI

kr135.20

Ultimovacs

7D

-0.3%

1Y

5.5%

CRNA

kr6.30

Circio Holding

7D

3.3%

1Y

-75.4%

LYTIX

kr6.50

Lytix Biopharma

7D

-4.4%

1Y

-20.1%

BGBIO

kr0.22

BerGenBio

7D

-28.8%

1Y

-96.9%

PCIB

kr1.92

PCI Biotech Holding

7D

-1.3%

1Y

-26.8%

NANOV

kr2.00

Nordic Nanovector

7D

-18.3%

1Y

-22.2%